eye drugs Flashcards
antimuscarinics
atropine, homotropine, tropicamide, cyclopentolate, scopolamine
antimuscarinics side effects
increases intraocular pressure, transiently stings, burns
systemic : dry mouth, skin, photophobia, tachycardia, palpitations, headache, somnolence
antimuscarinics contraindications
glaucoma and sulfite preservative allergy
1st line for glaucoma
prostaglandin analogs: latanoprost, travoprost, bimatoprost
beta-receptors antagonists for glaucoma
timolol maleate, levobunolol, metipranolol, carteolol
carbonic anhydrase (isoenzyme II) inhibitors
dorzolamide, brinzolamide, acetazolamide
PGF2alpha analog mechanism
unclear, thought to facilitate aqueous outflow via accessory uveoscleral outflow pathway
PGF2alpha metabolism
isopropyl ester pro-drugs that undergo in situ hydrolysis after penetrating cornea
PGF2alpa side effects
acute: blurred vision, stinging/burning, itching
chronic: slow and permanent brown pigmentation of iris, eyelid skin, and eyelashes, also increasing growth and thickness
beta-blocker effects
decrease aqueous humor production by decreasing cAMP-PKA stimulation; decrease ocular bloodflow and ultrafiltration producing humor
beta-blocker side effects;
systemic effects after topical dose; damages contacts
carbonic anhydrase inhibitor moa
reduce bicarbonate secretion and fluid transport, decreasing IOP
carbonic anhydrase inhibitors adverse effects
25% experience dysgeusia (bitter taste)
sulfonamide drugs: allergic reactions - agranulocytosis, aplastic anemia, fulminant hepatic necrosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, and other blood dyscrasias
muscarinic agonists and cholinesterase inhibitors moa
increase aqueous humor flow; direct acting miotics
muscarinic agonists and cholinesterase inhibitors contraindications
iritis, uveitis, inflammatory condition of anterior chamber, CV disease, asthma, PUD,
muscarinic agonists and cholinesterase inhibitors adverse effects
decreased night vision; caution in patients with cholinergic-mediated medical conditions (CHF, asthma, GI, etc.)
cholinesterase inhibitors pharm
more potent and longer acting miotics; more adverse effects
echothiophate moa
cholinesterase inhibitor
carbachol, pilocarpine, and acetylcholine HCL moa
muscarinic agonists
alpha-2 specific
apraclonidine and brimonidine
non-specific alpha agonists
phenylephrine, naphazoline, tetrahydroxoline
sympathomimetics moa in eye
decrease IOP by increasing outflow of aqueous humor
veteporfin moa
generates free radicals leading to vessel damage and subsequent platelet activation, thrombosis, and occlusion of choroidal neovascularization
veteporfin adverse effects
headache, injection-site reactions, visual disturbances, temporary photosensitization